These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26490986)

  • 1. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
    Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
    Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.
    Zhou J; Shen W; He X; Qian J; Liu S; Yu G
    Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.
    Li C; Li X; Wu L; Jiang Z
    Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
    Sun Q; Li F; Sun F; Niu J
    Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
    Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Englisch JP; Wiltberger G; Schierle K; Robson SC; Reutzel-Selke A; Jonas S; Pascher A; Pratschke J; Schmelzle M
    J Surg Oncol; 2016 Jul; 114(1):91-8. PubMed ID: 27111031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
    Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines.
    Chen YJ; Xiong XF; Wen SQ; Tian L; Cheng WL; Qi YQ
    Genet Mol Res; 2015 Jun; 14(2):7053-61. PubMed ID: 26125915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma.
    Sun Q; Li F; Yu S; Zhang X; Shi F; She J
    Biomed Res Int; 2018; 2018():6135016. PubMed ID: 29862278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of macrophage invasion in hilar cholangiocarcinoma.
    Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Wiltberger G; Matia I; Prager I; Schierle K; Robson SC; Reutzel-Selke A; Pratschke J; Schmelzle M; Jonas S
    BMC Cancer; 2015 Oct; 15():790. PubMed ID: 26497197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma.
    Xu D; Yi W; Chen Y; Ma L; Wang J; Yu G
    Med Oncol; 2014 Dec; 31(12):261. PubMed ID: 25344871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
    Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
    BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
    Hurley PJ; Marchionni L; Simons BW; Ross AE; Peskoe SB; Miller RM; Erho N; Vergara IA; Ghadessi M; Huang Z; Gurel B; Park BH; Davicioni E; Jenkins RB; Platz EA; Berman DM; Schaeffer EM
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14977-82. PubMed ID: 22927397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma.
    Feng Y; Bai Z; Song J; Zhang Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
    Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
    Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.